Sweden leads dementia drug research but care lags, Alzheimerfonden says

Sweden has prominent dementia researchers and a world-unique drug development pipeline, but dementia care and support are inadequate, according to Alzheimerfonden's Secretary General. The contrast highlights a gap between research excellence and clinical practice. This is a domestic health-science development with no immediate market impact.